BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29998863)

  • 1. Isotretinoin and dermatosurgical procedures.
    Mysore V; Omprakash HM; Khatri GN
    Indian J Dermatol Venereol Leprol; 2019; 85(1):18-23. PubMed ID: 29998863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients.
    Chandrashekar BS; Varsha DV; Vasanth V; Jagadish P; Madura C; Rajashekar ML
    Int J Dermatol; 2014 Oct; 53(10):1281-5. PubMed ID: 25039864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations.
    Spring LK; Krakowski AC; Alam M; Bhatia A; Brauer J; Cohen J; Del Rosso JQ; Diaz L; Dover J; Eichenfield LF; Gurtner GC; Hanke CW; Jahnke MN; Kelly KM; Khetarpal S; Kinney MA; Levy ML; Leyden J; Longaker MT; Munavalli GS; Ozog DM; Prather H; Shumaker PR; Tanzi E; Torres A; Velez MW; Waldman AB; Yan AC; Zaenglein AL
    JAMA Dermatol; 2017 Aug; 153(8):802-809. PubMed ID: 28658462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermabrasion for acne scars during treatment with oral isotretinoin.
    Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
    Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safe delivery of fractional ablative carbon dioxide laser treatment for acne scars in Asian patients receiving oral isotretinoin.
    Kim HW; Chang SE; Kim JE; Ko JY; Ro YS
    Dermatol Surg; 2014 Dec; 40(12):1361-6. PubMed ID: 25361201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of Laser Hair Removal in Patients Receiving Systemic Isotretinoin for Acne Vulgaris.
    Sarigul Guduk S; Tukenmez Demirci G
    Dermatol Surg; 2021 Nov; 47(11):1448-1452. PubMed ID: 34537789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acne fulminans following low-dose isotretinoin and testosterone use.
    Barańska-Rybak W; Mehrholz D; Flis P; Karpinsky G; Sokołowska-Wojdyło M
    Cutis; 2019 Jun; 103(6):E20-E21. PubMed ID: 31348466
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early chemabrasion for acne scars after treatment with oral isotretinoin.
    Picosse FR; Yarak S; Cabral NC; Bagatin E
    Dermatol Surg; 2012 Sep; 38(9):1521-6. PubMed ID: 22687256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
    Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Night blindness following low-dose isotretinoin.
    Halpagi P; Grigg J; Klistorner A; Damian DL
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
    Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory segmental vitiligo during oral isotretinoin use: a casual association?
    Avelar-Caggiano MFS; Castro CCS; Dellatorre G
    An Bras Dermatol; 2020; 95(3):399-400. PubMed ID: 32299740
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
    Rigopoulos D; Larios G; Katsambas AD
    Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isotretinoin Therapy for Acne Vulgaris and First Episode Psychosis in an Adolescent Patient].
    Valderrama F; Gómez A; Restrepo D
    Rev Colomb Psiquiatr; 2017; 46(1):50-54. PubMed ID: 28193374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.